News Feed Opinion Career Insight Dialogues Blog
Positive Societies Drugs Stories History
December, 2023
December 2023
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Aruni Ghose: We did not identify differences in the management or short-term outcomes of patients with OPSCC treated at Barts Cancer Centre before and during the COVID-19 pandemic
Photo taken from Aruni Ghose/LinkedIn
Oct 15, 2023, 15:11

Aruni Ghose: We did not identify differences in the management or short-term outcomes of patients with OPSCC treated at Barts Cancer Centre before and during the COVID-19 pandemic

Aruni Ghose, Council Member of Oncology Section at , shared on LinkedIn:

“The Royal College of Radiologists Annual Conference 2023 presenting:-

‘A Single Centre UK Service Evaluation and Comparison of outcomes of radically treated HPV associated Oropharyngeal Squamous Cell Carcinoma before and during the COVID-19 pandemic’

In today’s oncology world, there is a landscape of big clinical trials and real world evidence. We wanted to reflect on our own services and henceforth did this Service Evaluation for Improvement. Mentored by Sherif Raouf supervised by Pandora Rudd Kieran P. we did not identify differences in the management or short-term outcomes of patients with OPSCC treated at Barts Cancer Centre before and during the COVID-19 pandemic, indicating that the service was maintained despite challenges. Time from referral to MDT, MDT to Surgery were unknown but could have influenced treatment modality. Inclusion of a larger number of patients from other centres with longer follow up times is planned to confirm whether these findings are consistent in other populations at multiple NHS sites.

Find our poster at COW42.”

Source: Aruni Ghose/LinkedIn

Aruni Ghose Barts Cancer Centre cancer Kieran P. OncoDaily Oncology Pandora Rudd Sherif Raouf
Insight
Dec 9, 2023, 04:44
President Biden: It's good for the millions of Americans who can't afford their medications
Blog
Dec 9, 2023, 00:38
Thomas Hofmarcher: This is what a great panel discussion looks like!
Blog
Dec 9, 2023, 00:32
Zhiheng Xu: It's not just about how much statistics you know
Blog
Dec 9, 2023, 00:23
Priscilla Chan: Mark and I wrote our annual letter this year about how some of our earliest bets in science are letting us take advantage of this moment in AI
Blog
Dec 9, 2023, 00:18
David Fajgenbaum: 1 in 10 of us will develop a disease with no treatments
Career
Dec 8, 2023, 17:54
Dana-Farber News congratulates Sara Tolaney on receiving the Susan G. Komen 2023 Rising Star Researcher Award
Drugs
Dec 8, 2023, 17:50
Pure Biologics to test molecule PBA-0405 in project PB004 in a Phase 0 clinical trial in patients with solid tumors - The Antibody Society
Drugs
Dec 8, 2023, 17:46
Earle Burgess: Interested in new treatments being developed for advanced (urothelial) bladder cancer?
Insight
Dec 8, 2023, 17:40
Ibrahim Halil Sahin: A common question I received after my tweet on the PEGASUS trial...
Career
Dec 8, 2023, 17:35
Timothy M. Pawlik: Excited to announce Samilia Obeng-Gyasi as THE inaugural Endowed Surgical Professor in Health Equity
Insight
Dec 8, 2023, 17:32
Daniel Stover: Tumor genomic testing (TGT) is standard for MBC patients
Blog
Dec 8, 2023, 17:27
Tedros Adhanom Ghebreyesus: Gaza cannot afford to lose any more hospitals…
Insight
Positive
Societies
Career